Biomedical literature, made navigable
Discover articles through diseases, drugs, treatments, interventions, clinical instruments, institutions and funders extracted from the BMJ open corpus.
An entity family is a category of extracted information. Choose one to browse its named entities and supporting articles.
Organisations named as supporting, sponsoring, or funding research.
5,089 articles · 9,137 mentionsInstitutionsUniversities, hospitals, research centres, networks, and public bodies.
11,350 articles · 22,378 mentionsDrugsNamed medicines, compounds, vaccines, and pharmacological agents.
10,506 articles · 58,393 mentionsDiseasesNamed diseases, disorders, syndromes, injuries, and health conditions.
23,712 articles · 125,551 mentionsTreatmentsClinical therapies and care approaches used to manage a condition.
7,227 articles · 16,644 mentionsInterventionsProgrammes, procedures, policies, and other actions being evaluated.
4,132 articles · 9,994 mentionsClinical instrumentsNamed questionnaires, scales, scores, indices, and other clinical outcome assessments.
945 articles · 1,957 mentionsChoose an entity to see the articles in which it was identified.
…hown to reduce disease flares during pregnancy in patients with systemic lupus erythematosus and to improve pregnancy outcomes.Objectives To evaluate the im…
…Background Apical hypertrophic cardiomyopathy (HCM) is a rare variant of HCM, often considered to have a beni…
… approach to COVID-19 vaccination. Opportunities exist to focus COVID-19 vaccination integration efforts in a way that sets the stage fo…
…ancial restrictions, distance to healthcare and stigma hindered hypertension management. Residents in these coastal communities tend to unde…
…mphoma. These results do not support same-day administration of pegfilgrastim .…
…se to methotrexate, he was subsequently shifted to intravitreal rituximab injections. He received monthly intravitreal injections of ritu…
…), 0.3 days for Dapagliflozin (95%CI 0.4–0.2), and 0.3 days for Alendronic Acid (95%CI 0.4–0.2).Dispensing practices more consistently prescrib…
… evaluate the effect of CD24 on the sensitivity of HCC cells to sorafenib. The integration of RNA sequencing, flow cytometry, cell chemot…
…he therapeutic range (10–20 µg/mL) (p <0.001). Of the total 238 vancomycin trough concentrations taken from patients, 77 (32.4%) were meas…
…Treatment non-adherence in adolescents with Inflammatory Bowel Disease (IBD) is as high as 93%. 1 Non-adherence to treatment has signi…